Literature DB >> 7555466

Conventional dose of omeprazole alters gastric flora.

Y Karmeli1, R Stalnikowitz, R Eliakim, G Rahav.   

Abstract

Quantitative cultures were carried out on samples from gastric juice obtained from 12 ambulatory patients with esophagitis before and one month after omeprazole therapy. An increase in the number of patients in whom gastric juice was culture-positive, as well as an increment in the bacterial counts were noted. The spectrum of microorganisms isolated from gastric juice was identical to the normal flora of the oral cavity, mainly alpha-hemolytic streptococci, corynebacteria, and Candida species. Thus, the counts of organisms within gastric contents are simply a reflection of swallowed oral microflora that were able to survive due to the less acidic environment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555466     DOI: 10.1007/bf02208680

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

Review 1.  Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective.

Authors:  R A Giannella; S A Broitman; N Zamcheck
Journal:  Ann Intern Med       Date:  1973-02       Impact factor: 25.391

2.  Prevention of acute stress bleeding with sucralfate, antacids, or cimetidine. A controlled study with pirenzepine as a basic medication.

Authors:  M Tryba; F Zevounou; M Torok; M Zenz
Journal:  Am J Med       Date:  1985-08-30       Impact factor: 4.965

3.  Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway.

Authors:  G C du Moulin; D G Paterson; J Hedley-Whyte; A Lisbon
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

4.  Antacids--a risk factor in travellers brucellosis?

Authors:  R Steffen
Journal:  Scand J Infect Dis       Date:  1977

Review 5.  The protective role of gastric acid.

Authors:  R H Hunt
Journal:  Scand J Gastroenterol Suppl       Date:  1988

6.  Stomach as source of bacteria colonising respiratory tract during artificial ventilation.

Authors:  S T Atherton; D J White
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

7.  Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment.

Authors:  G J Milton-Thompson; N F Lightfoot; Z Ahmet; R H Hunt; J Barnard; P M Bavin; R W Brimblecombe; D W Darkin; P J Moore; N Viney
Journal:  Lancet       Date:  1982-05-15       Impact factor: 79.321

8.  Duodenal bacterial overgrowth during treatment in outpatients with omeprazole.

Authors:  M Fried; H Siegrist; R Frei; F Froehlich; P Duroux; J Thorens; A Blum; J Bille; J J Gonvers; K Gyr
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy.

Authors:  L G Donowitz; M C Page; B L Mileur; S H Guenthner
Journal:  Infect Control       Date:  1986-01

10.  Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells.

Authors:  D E Woods; D C Straus; W G Johanson; J A Bass
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

View more
  13 in total

1.  Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids.

Authors:  J Theisen; D Nehra; D Citron; J Johansson; J A Hagen; P F Crookes; S R DeMeester; C G Bremner; T R DeMeester; J H Peters
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

2.  Acid suppression therapy as a risk factor for Candida esophagitis.

Authors:  Kyung-Yup Kim; Jae Young Jang; Jung-Wook Kim; Jae-Jun Shim; Chang Kyun Lee; Seok Ho Dong; Hyo Jong Kim; Byung-Ho Kim; Young Woon Chang
Journal:  Dig Dis Sci       Date:  2013-01-10       Impact factor: 3.199

3.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.

Authors:  D Nehra; P Howell; C P Williams; J K Pye; J Beynon
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

4.  Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?

Authors:  Robin L P Jump; Michael J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

5.  Fluconazole Resistant Candida Oesophagitis in Immunocompetent Patients: Is Empirical Therapy Justifiable?

Authors:  Barnali Kakati; Aarti Kotwal; Debasis Biswas; Shantanu Sahu
Journal:  J Clin Diagn Res       Date:  2015-12-01

Review 6.  Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.

Authors:  Sangita Biswas; Stephen H Benedict; Sharon G Lynch; Steven M LeVine
Journal:  BMC Med       Date:  2012-06-07       Impact factor: 8.775

7.  Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report.

Authors:  Kuo-Hsin Chen; Meng-Tzu Weng; Yueh-Hung Chou; Yueh-Feng Lu; Chen-Hsi Hsieh
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

8.  Predictors of esophageal candidiasis among patients attending endoscopy unit in a tertiary hospital, Tanzania: a retrospective cross-sectional study.

Authors:  Martha F Mushi; Nathaniel Ngeta; Mariam M Mirambo; Stephen E Mshana
Journal:  Afr Health Sci       Date:  2018-03       Impact factor: 0.927

9.  Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea.

Authors:  Jae Hyeuk Choi; Chang Geun Lee; Yun Jeong Lim; Hyoun Woo Kang; Chi Yeon Lim; Jong-Sun Choi
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

Review 10.  Oesophageal candidiasis in elderly patients: risk factors, prevention and management.

Authors:  Namal Weerasuriya; Jeremy Snape
Journal:  Drugs Aging       Date:  2008       Impact factor: 4.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.